All News #Library
Biotech
Kaken Strengthens Late-Stage HAE Portfolio with $32 M Astria Deal
09 Aug 2025 //
FIERCE BIOTECH
KalVista sells Japanese rights for HAE drug to Kaken
08 Apr 2025 //
BUSINESSWIRE
Whitehawk Completes Sale of Aadi Subsidiary to Kaken Pharma
26 Mar 2025 //
PR NEWSWIRE
Alumis and Kaken Pharma Collaborate on ESK-001 in Japan
25 Mar 2025 //
GLOBENEWSWIRE

Market Place
Sourcing Support